One of the largest clinical trials for prostate cancer has given “powerful results”, say UK researchers.
A drug for treating prostate cancer that has spread was found to save lives when offered earlier, a study found.
The trial looked at abiraterone as an additional treatment in patients with prostate cancer who were about to start long-term hormone therapy.
Abiraterone improved survival, according to results published in the New England Journal of Medicine.
Prof Nicholas James, from the University of Birmingham, who led the research, said: “These are the most powerful results I’ve seen from a prostate cancer trial – it’s a once-in-a-career feeling.
Copyright BBC 2018